Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Capsaicin for Cyclical Vomiting Syndromes
NCT03223350Phase 2Completed
- Sponsor
- Henry Ford Health
- Start
- Dec 2017
- Primary completion
- Aug 2019
- Modality
- Transdermal Patches, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of capsaicin 8% patch in cyclic vomiting syndrome (CVS), Cannabinoid hyperemesis syndrome (CHS), sponsored by Henry Ford Health. Started Dec 2017; status: completed.
02
Drugs
capsaicin 8% patch
03
Conditions
cyclic vomiting syndrome (CVS)Cannabinoid hyperemesis syndrome (CHS)
Beyond the preview
Go deeper on NCT03223350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03223350.